Endovastec has repurchased a total of 1.2287 million shares, costing 129 million yuan
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Endovastec announced that as of August 31, 2025, the company has repurchased a total of 1,228,700 shares through the centralized bidding trading method (Phase II) via the Shanghai Stock Exchange trading system, with the highest transaction price being RMB 120.00 per share, the lowest price being RMB 84.26 per share, and the total amount of funds paid being RMB 129 million (excluding stamp duty, transaction commissions, and other transaction costs)
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments